News

Moxie Establishes Clinical Advisory Board for Aesthetic Growth

Moxie Establishes Clinical Advisory Board for Aesthetic Growth

Moxie Forms Clinical Advisory Board to Enhance Aesthetic Practices

Moxie, a comprehensive solution designed specifically for medspa entrepreneurs, is excited to announce the creation of its inaugural Clinical Advisory Board. This board will combine the talents of key opinion leaders in the aesthetic medicine field to provide strategic guidance for over 250 independent medspas that Moxie supports.

The Clinical Advisory Board presents an exceptional opportunity for collaboration among some of the most distinguished names in aesthetic medicine. These experts bring a wealth of knowledge covering various specialties such as facial plastics, injectables, and regenerative medicine. The intention behind this advisory board is to bolster the network of medspas through expert insights and shared innovation.

Meet the Inaugural Members

The members visible in this pioneering advisory board include two of the most talented professionals in the field. Dr. Sheila Barbarino, who owns Barbarino Surgical Arts, is an esteemed cosmetic surgeon recognized for her spectacular results and contributions to the medical aesthetic community. Her extensive experience includes lecturing globally, offering training on advanced techniques for injectables and lasers, and publishing numerous articles in reputable medical journals.

Alongside her is Dr. David Saadat, who heads the Beverly Hills Aesthetic Surgical Institute. With over two decades of experience, Dr. Saadat is a board-certified plastic surgeon specializing in facial aesthetics and regenerative medicine. His commitment to training is evident through hands-on programs designed for both aesthetic providers and surgical residents, all while staying at the forefront of innovative techniques and knowledge in the space.

Dan Friedman, the CEO of Moxie, expressed enthusiasm regarding this collaboration. He noted that, "Our partnership with leading experts like Dr. Saadat and Dr. Barbarino allows us to provide independent practitioners with the essential support they need. Our goal is to empower these practitioners with the tools necessary to provide safe, effective care to their patients while supporting their growth and success."

Both doctors also shared their enthusiasm for joining the advisory board, with Dr. Barbarino emphasizing Moxie's role in fostering a community that guides new medspa entrepreneurs. "Moxie shines a light on the path to a successful practice centered on patient care, enabling owners to navigate challenges without losing focus on what truly matters," she said.

Dr. Saadat echoed this sentiment, underlining the importance of building a collaborative community within the aesthetic field: "The primary purpose of our involvement is to enhance understanding in practice management to better patient outcomes. Moxie's initiatives are key to achieving this mission."

Defining Objectives of the Advisory Board

The establishment of the Clinical Advisory Board is a significant step forward with ambitious goals:

  • Treatment Innovation: This includes advising on the latest advancements and trends in aesthetic treatments to ensure cutting-edge techniques are utilized.
  • Education & Training: Focusing on enhancing educational programs for practitioners so they maintain expertise in a rapidly evolving field.
  • Business Strategy: Establishing best practices designed to improve the efficiency and profitability of the medspas supported by Moxie.

The aesthetic medicine industry is on a trajectory of robust growth, with forecasts estimating its value to reach around $17 billion in the upcoming years. Moxie is dedicated to empowering independent medspas by equipping them with the same resources and advantages enjoyed by large chains.

About Moxie

Moxie specializes in providing medical professionals with an all-in-one solution aimed at launching and sustaining successful medspa businesses. By incorporating a combination of innovative software, strategic consulting, marketing strategies, and efficient back-office solutions, Moxie facilitates entrepreneurs in creating profitable and compliant medspa businesses. Moxie’s commitment to streamlining operations and reducing unnecessary hurdles means that launching a medspa can be an invigorating and fulfilling journey rather than a daunting one.

For those interested in more information about Moxie's services and support, please visit their official website.

Frequently Asked Questions

What is Moxie's Clinical Advisory Board?

The Clinical Advisory Board is a new initiative from Moxie that brings together leading experts in aesthetic medicine to offer guidance and support to independent medspas.

Who are the members of the Clinical Advisory Board?

The members include notable professionals such as Dr. Sheila Barbarino and Dr. David Saadat, both recognized for their contributions and expertise in the field.

What are the goals of the Clinical Advisory Board?

Its goals include promoting treatment innovation, education and training, and business strategy development to enhance the success of supported medspas.

How does Moxie support medspa entrepreneurs?

Moxie provides an all-in-one solution that integrates software, consulting, marketing, and operational support, facilitating the growth of medspa practices.

What is the anticipated growth of the aesthetic medicine industry?

Experts project that the aesthetic medicine industry will reach approximately $17 billion in value in the forthcoming years, indicating significant market potential.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Updated Category News Views 84

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Continue Reading
Gala Spotlights Veterans' Mental Health Support

Updated Category News Views 11

Champions for Veterans Honored at Headstrong Gala If you ever wondered who stands in the trenches alongside veterans facing mental health battles, this year's Headstrong Gala offered a crystal-clear answer. Held on October 16 at Pier Sixty in New York City, this shiindig wasn’t just about schmoozing over canapés. It was about celebrating the grit and guts of those...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 21

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading
FOX News Revamps 2026 Election Coverage Playbook

Updated Category News Views 124

Revamped Coverage: More Than Just Breaking News Yeah, everyone's clamoring about the midterms, but Fox News is doing more than just flipping on the camera and breaking the news every few minutes this year. They're rolling out the big guns: AI chatbots, flashy graphics, and special shows across multiple platforms. The point? To get viewers practically hooked and give 'em...

Continue Reading
GoldMining's 2025 Report: Zero Incidents, Big Green Goals

Updated Category News Views 12

GoldMining Inc. Shows a Clear Green Streak Sometimes, you're caught off guard by a company's clear dedication to getting things right, and GoldMining Inc.'s latest sustainability report shows they're not just chasing fool's gold. They've laid out a solid roadmap. With the rollers they've got—swapping environmental chaos for responsible exploration—these guys have...

Continue Reading
Egan-Jones CLO Metrics Strong Amid Rate Hikes

Updated Category News Views 26

Interest Rates Climb, CLO Metrics Hold Firm Buckle up, folks. As interest rates drift higher like a stubborn balloon, investors are scouring the landscape for any sign of a shaky foundation. Well, here's a bit of solace in the storm: Egan-Jones, the credit rating powerhouse, has released their latest musings on the collateralized loan obligation (CLO) market...

Continue Reading
Biotech's Future Faces Tight Investment Restrictions

Updated Category News Views 34

Biotech Investment: Between a Rock and a Hard Place The U.S. Department of the Treasury just threw a curveball at the biotechnology sector with its proposal to shore up the Comprehensive Outbound Investment National Security (COINS) Act. This ain't just another set of lines on a folded napkin; the new rules would put a chokehold on American investments flowing into...

Continue Reading
Endava Faces Class Action as Price Plunges 25%

Updated Category News Views 39

Troubled Waters for Endava's Investors The corporate waters churn as Endava plc (NYSE:DAVA) finds itself slapped with a securities class action lawsuit. This legal storm rises amid talks of delayed financials and whispers of potential accounting frippery, sending shockwaves that slashed the company's stock price by a bone-rattling 25% on September 22, 2026. Now, investors...

Continue Reading
Cboe Clear's US Move: A New Chapter with SEC Nod

Updated Category News Views 41

Clearing the Path for New Beginnings The ink's barely dry on Cboe Clear U.S.'s recent SEC registration, and it's already setting tongues wagging among market old-timers. This move to clear binary securities options alongside futures isn't just a step up; it's a signal flare for ambitious innovation. The Nuts and Bolts: SEC Registration So, what's the big to-do? Cboe Clear...

Continue Reading
Vinitaly.USA 2026: Italian Wine Takes Manhattan

Updated Category News Views 11

A Two-Day Wine Extravaganza Hits New York If Italian wine was a stock, the Vinitaly.USA 2026 gathering in New York would be a rallying cry to double down. October 26-27 is set to be a whirl of handshakes and clinking glasses at Pier 36, all under the grand vision of beefing up Italy's hold on the U.S. wine market. As the compass points to growing opportunities, one can't...

Continue Reading

Top 5 Most Recently Viewed Articles

BankUnited's Stock Reaches New Heights with Strong Growth

Updated Category News Views 89

BankUnited Inc. Achieves New 52-Week High BankUnited Inc. (NYSE: BKU) has recently made headlines by reaching a remarkable 52-week high of $41.74. This surge signifies not only a peak in stock price but also a notable increase in investor confidence towards the bank. With a striking 1-year change of 54.44%, this upward trend is a reflection of strong financial performance...

Continue Reading
Exploring the Future of Floating Solar Panels in Energy Sector

Updated Category News Views 149

Floating Solar Panels: A Growing Market The floating solar panels market is witnessing remarkable growth, with estimates indicating a surge from approximately USD 1.06 billion to USD 3.39 billion by the decade's end. This growth is fueled by various factors, including escalating demand for renewable energy, which is becoming increasingly vital in mitigating climate change...

Continue Reading
OSB Group Executes Share Buyback with Significant Volume

Updated Category News Views 60

Overview of OSB Group PLC's Share Buyback OSB GROUP PLC ISIN: GB00BLDRH360 LEI number: 213800ZBKL9BHSL2K459 The Company is pleased to announce a strategic move involving the purchase of a total of 66,483 of its ordinary shares. These transactions were executed on the London Stock Exchange through its designated broker, Citigroup Global Markets Limited. Following the...

Continue Reading
Aurora Admin's Real-Time Alerts: Catch the Magic of the Lights

Updated Category News Views 171

Revolutionizing Aurora Forecasting with Aurora Admin Aurora Admin has unveiled a game-changing service that enables enthusiasts to catch the breathtaking Northern and Southern Lights as they happen. Founded by aurora enthusiast Josh S, this innovative platform utilizes state-of-the-art technology to deliver real-time alerts through SMS. Users across more than 40 countries...

Continue Reading
Pascal Picano Joins Willis Lease Finance as Senior VP of Leasing

Updated Category News Views 190

Willis Lease Finance Corporation Welcomes New Leadership Willis Lease Finance Corporation (NASDAQ: WLFC), renowned for its role as a leading lessor of commercial aircraft engines and a global provider of aviation services, is excited to announce a new addition to its executive team. Pascal Picano has been appointed as the Senior Vice President of Aircraft Leasing &...

Continue Reading